aap Implantate AG announced that its innovative antibacterial silver coating technology will be further funded by the German Federal Ministry of Education and Research . aap can receive grants of up to around EUR 2.7 million for expenses incurred by carrying out the human clinical study for the intended market approval of its silver coating technology. In a first step, aap received a funding commitment of up to about EUR 0.7 million for the conception and qualification of the human clinical study. Following the recent approval of the human clinical study by the Federal Institute for Drugs and Medical Devices, aap now still needs the approval of the ethics commissions in view of the start of the study in Germany. Furthermore, the doctors participating in the study have already been trained in recent months and the equipment of the corresponding clinics with silver-coated implants has been prepared. The benefit granted to the company is part of the BMBF's 'Health Industry in the Health Research Framework Programme' field of action. According to the BMBF, funding will be provided for projects on the topic of 'Transferring medical technology solutions into patient care - proving clinical evidence without delay'.